Edition:
India

People: ARCA Biopharma Inc (ABIO.OQ)

ABIO.OQ on NASDAQ Stock Exchange Capital Market

5.36USD
18 Oct 2019
Change (% chg)

$0.06 (+1.13%)
Prev Close
$5.30
Open
$5.33
Day's High
$5.44
Day's Low
$5.33
Volume
717
Avg. Vol
22,270
52-wk High
$20.40
52-wk Low
$4.72

Ozeroff, Christopher 

Mr. Christopher David Ozeroff is Senior Vice President, General Counsel, Secretary of ARCA biopharma Inc.Previously, Mr. Ozeroff served as the Company’s Executive Vice President of Business Development, General Counsel and Secretary since the merger with Nuvelo. Before the merger, Mr. Ozeroff was one of the founders of ARCA Colorado in September 2004, and had served as its Executive Vice President of Business Development, General Counsel and Secretary since that date. From August 1999, Mr. Ozeroff was previously a partner with the law firm of Hogan & Hartson L.L.P., where he practiced in such areas as finance, acquisitions, public offerings, and licensing. Mr. Ozeroff completed his undergraduate degree at Stanford University and his law degree at the University of Chicago Law School.

Basic Compensation

Total Annual Compensation, USD 285,584
Restricted Stock Award, USD 66,690
Long-Term Incentive Plans, USD --
All Other, USD 27,894
Fiscal Year Total, USD 380,168

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --